<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Mice treated with high-dose <z:chebi fb="0" ids="28901">busulfan</z:chebi> develop a 'latent' form of <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo> characterized by near-<z:mpath ids='MPATH_458'>normal</z:mpath> peripheral blood counts and marrow cellularity, but marked reductions in marrow pluripotent stem cells (CFUs) and myeloid progenitor cells (CFUc) </plain></SENT>
<SENT sid="1" pm="."><plain>Spleen cell suspensions from control and 'latent' mice were placed in liquid culture in the presence of colony-stimulating activity </plain></SENT>
<SENT sid="2" pm="."><plain>Cells were harvested at intervals up to 14 days and sub-cultured in agar to assay for CFUc </plain></SENT>
<SENT sid="3" pm="."><plain>Baseline splenic CFUc did not differ significantly between control and 'latent' mice </plain></SENT>
<SENT sid="4" pm="."><plain>Splenic CFUc from control mice increased 50-fold and reached a peak at day 10 in liquid culture </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast, splenic CFUc from 'latent' mice increased only 7-fold and reached a peak at day 3 </plain></SENT>
<SENT sid="6" pm="."><plain>Our results indicate that although splenic CFUc are present in <z:mpath ids='MPATH_458'>normal</z:mpath> numbers in 'latent' mice, their proliferative capacity is markedly reduced, either as the result of defective CFUc self-renewal or defective feed-in from CFUs or both </plain></SENT>
</text></document>